Amarin Corp Plcuk (AMRN) Leases (2010 - 2026)
Amarin Corp Plcuk (AMRN) reported Leases of $6.0 million for Q1 2026, down 28.45% year-over-year from $8.4 million in Q1 2025, and down 7.54% quarter-over-quarter from $6.5 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Leases (2010 - 2026) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 13 years of Leases data on file, last reported at $6.0 million in Q1 2026.
- Leases for Q1 2026 came in at $6.0 million, down 28.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (down 28.45% YoY), and the FY2025 annual result was $6.5 million, down 14.47% from the prior year.
- Leases slipped to $6.0 million in Q1 2026 per AMRN's latest filing, from $6.5 million in the prior quarter.
- Over five years, Leases peaked at $9.2 million in Q1 2023 and troughed at $6.0 million in Q1 2026.
- A 5-year average of $8.0 million and a median of $8.3 million in 2023 frame the typical range for Leases.
- The sharpest annual moves came in 2022 and 2026: Leases grew 18.8% in 2022, then declined 28.45% in 2026.
- A 5-year view of Leases shows it stood at $9.1 million in 2022, then fell by 8.68% to $8.3 million in 2023, then retreated by 8.54% to $7.6 million in 2024, then fell by 14.47% to $6.5 million in 2025, then retreated by 7.54% to $6.0 million in 2026.
- Business Quant data shows AMRN's Leases at $6.0 million in Q1 2026, $6.5 million in Q4 2025, and $7.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 941.03 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | - |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | - |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 1.53 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn | 6.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.01 Mn |
| Dec 31, 2025 | 6.50 Mn |
| Sep 30, 2025 | 7.20 Mn |
| Jun 30, 2025 | 7.64 Mn |
| Mar 31, 2025 | 8.40 Mn |
| Dec 31, 2024 | 7.60 Mn |
| Sep 30, 2024 | 7.98 Mn |
| Jun 30, 2024 | 7.54 Mn |
| Mar 31, 2024 | 7.90 Mn |
| Dec 31, 2023 | 8.31 Mn |
| Sep 30, 2023 | 8.51 Mn |
| Jun 30, 2023 | 8.98 Mn |
| Mar 31, 2023 | 9.20 Mn |
| Dec 31, 2022 | 9.10 Mn |
| Sep 30, 2022 | 8.46 Mn |
| Jun 30, 2022 | 8.60 Mn |
| Mar 31, 2022 | 8.70 Mn |
| Dec 31, 2021 | 7.66 Mn |
| Sep 30, 2021 | 7.76 Mn |
| Jun 30, 2021 | 7.90 Mn |